← All indications
Tuberculosis, Pulmonary
MYCOBACTERIUM infections of the lung.
Subtype terms (1)
More specific conditions that are subtypes of Tuberculosis, Pulmonary in the MeSH hierarchy.
Drugs by status
Approved for this indication (12)
Phase 4 trials (7)
Phase 3 trials (17)
Phase 2 trials (46)
- metformin
- azacitidine
- pascolizumab
- acetylcysteine
- procaine benzylpenicillin
- clavulanate
- doxycycline
- ibuprofen
- faropenem medoxomil
- lcb01-0371
- dolutegravir
- rosuvastatin
- amoxicillin
- cetrorelix
- sodium phenylbutyrate
- sutezolid
- pravastatin
- qinbudan
- acetylsalicylic acid
- sq109
- emtricitabine
- gla-se
- Ganfeborole
- id93
- ruti
- bupropion
- azithromycin
- ic31
- bictegravir
- midazolam
- +16 more
Phase 1 trials (9)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (42)
- Sanofi
- Bandim Health Project
- Huazhong University of Science and Technology
- Aarhus University
- Anhui Medical University
- Federal University of Mato Grosso do Sul
- Harbin Medical University
- Instituto Nacional de Enfermedades Respiratorias
- Kunming Medical University
- Osaka University
- Shanxi Medical University
- Xinjiang Medical University
- Capital Medical University
- Chongqing Medical University
- Fudan University
- The Fifth People's Hospital of Suzhou
- University of California, Los Angeles
- Zhejiang University
- National Taiwan University
- Government of China
- Tianjin University
- Bill and Melinda Gates Foundation
- Arla Foods
- Changchun Infectious Disease Hospital
- Public Health Clinical Center of Chengdu
- Taiyuan Fourth People's Hospital
- Sixth People's Hospital of Nantong
- Infectious Disease Prevention Hospital in Heilongjiang Province
- The Third People's Hospital of Zhenjiang
- Heilongjiang Province center for tuberculosis Control and Prevention
- +12 more
Organization Involved with Phase 3 Indications (121)
- Bayer
- Orient Pharma Co., Ltd.
- Epicentre
- AIDS Clinical Trials Group
- Global Alliance for TB Drug Development
- National Institutes of Health (NIH)
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- World Health Organization
- Australian National University
- University of London
- Harvard University
- Indian Council of Medical Research
- Institute of Tropical Medicine, Belgium
- Kenya Medical Research Institute
- King George's Medical University
- Johns Hopkins University
- Menzies School of Health Research
- Partners in Health
- Seoul National University
- University of Liverpool
- University of Melbourne
- University of Ottawa
- University of Bergen
- University of Bern
- University of Zurich
- Yonsei University
- Dalhousie University
- University of California, San Francisco
- University of Cape Town
- +91 more
Organization Involved with Phase 2 Indications (55)
- Celgene
- Pfizer
- GlaxoSmithKline
- LegoChem Biosciences, Inc
- Parexel
- Sequella, Inc.
- Otsuka
- Aeras
- Task Foundation NPC
- Infectious Disease Research Institute
- French National Agency for Research on AIDS and Viral Hepatitis
- National Institute for Medical Research, Tanzania
- Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- Addis Ababa University
- Armauer Hansen Research Institute, Ethiopia
- Baylor University
- Duke University
- Federal University of Bahia
- Radboud University
- Shanghai University of Traditional Chinese Medicine
- University of Groningen
- Columbia University
- Research Center Borstel
- Statens Serum Institut
- University of Ulsan
- Federal University of Rio de Janeiro
- Aurum Institute
- Badalona Hospital Germans Trias i Pujol
- University of the Witwatersrand
- International Center for Diarrheal Disease Research
- +25 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (14)
- Dow University of Health Sciences
- Shenzhen Third People's Hospital
- Justus Liebig University Giessen
- Aga Khan University
- Taipei Medical University
- Food and Drug Administration
- Sun Yat-Sen University
- Janssen Pharmaceutica NV
- Yunnan Provincial Hospital of Infectious Diseases
- University of Illinois at Chicago
- Indonesian Directorate General of Higher Education
- Johnson and Johnson
- The Fourth People’s Hospital of Nanning
- The Guangxi Zhuang Autonomous Region Longtan hospital